A Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of DR30303 in Patients With Advanced Solid Tumors
Clinical trial NCT05639153 · TERMINATED
Trial details
- NCT number
- NCT05639153
- Sponsor
- Zhejiang Doer Biologics Co., Ltd.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-13
- Primary completion
- 2025-12-30
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.